Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis - PubMed (original) (raw)
Comparative Study
doi: 10.1053/rmed.2002.1328.
Affiliations
- PMID: 12195834
- DOI: 10.1053/rmed.2002.1328
Free article
Comparative Study
Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis
M G Alexandrakis et al. Respir Med. 2002 Aug.
Free article
Abstract
Proinflammatory cytokines Interleukin-1 beta (IL-1 beta) and Interleukin-6 (IL-6) play a significant role in the pathogenetic processes related to various malignant and inflammatory conditions. Leukocytosis, thrombocytosis and increased acute phase protein levels are part of a systemic inflammatory response. In this study, we measured the concentrations of IL-1 beta, IL-6 and ferritin as well as hemoglobin, lactate dehydrogenase (LDH), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in 23 patients (male 15, female 8, median age 68 years) with lung cancer and reactive thrombocytosis (LCRT), in 27 (male 18, female 9, median age 64 years) with benign inflammatory lung disorder (BILD) and 18 (male 10, female 8, median age 62 years) lung cancer patients with a normal platelet count (LCNP). IL-1 beta levels were significantly higher in the three patient groups in comparison with control subjects (P < 0.001) but without significant difference among the three patient groups. IL-6 was higher in all three patients groups but only in the BILD group it was significantly higher than the control group (P < 0.05). However, no significant difference in IL-6 serum levels was found between the two lung cancer groups. CRP and LDH were significantly higher in the LCRT group in comparison with the other two patient groups (P < 0.01 and 0.001, respectively), while ferritin was higher in both lung cancer groups in comparison with the BILD group (P < 0.001). Our data suggest that in lung cancer patients, reactive thrombocytosis is part of the systemic inflammatory reaction for which IL-1 beta and IL-6 may be intermediate but not independent mediators.
Similar articles
- Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis.
Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, Coulocheri SA, Kyriakou DS. Alexandrakis MG, et al. Am J Clin Oncol. 2003 Apr;26(2):135-40. doi: 10.1097/00000421-200304000-00007. Am J Clin Oncol. 2003. PMID: 12714883 - Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders.
Ceresa IF, Noris P, Ambaglio C, Pecci A, Balduini CL. Ceresa IF, et al. Platelets. 2007 Dec;18(8):579-82. doi: 10.1080/09537100701593601. Platelets. 2007. PMID: 18041648 - Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins.
Araneda M, Krishnan V, Hall K, Kalbfleisch J, Krishnaswamy G, Krishnan K. Araneda M, et al. South Med J. 2001 Apr;94(4):417-20. South Med J. 2001. PMID: 11332909 - Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
Hsu HC, Tsai WH, Jiang ML, Ho CH, Hsu ML, Ho CK, Wang SY. Hsu HC, et al. J Lab Clin Med. 1999 Oct;134(4):392-7. doi: 10.1016/s0022-2143(99)90154-3. J Lab Clin Med. 1999. PMID: 10521086 - Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.
Unsal E, Aksaray S, Köksal D, Sipit T. Unsal E, et al. Postgrad Med J. 2005 Sep;81(959):604-7. doi: 10.1136/pgmj.2004.030544. Postgrad Med J. 2005. PMID: 16143693 Free PMC article.
Cited by
- Predicting survival for patients with mesothelioma: development of the PLACE prognostic model.
Zhang Y, Li N, Li R, Gu Y, Liu X, Zhang S. Zhang Y, et al. BMC Cancer. 2023 Jul 26;23(1):698. doi: 10.1186/s12885-023-11180-y. BMC Cancer. 2023. PMID: 37495975 Free PMC article. - Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors.
Rausch SM, Clark MM, Patten C, Liu H, Felten S, Li Y, Sloan J, Yang P. Rausch SM, et al. Cancer. 2010 Sep 1;116(17):4103-13. doi: 10.1002/cncr.25255. Cancer. 2010. PMID: 20564140 Free PMC article. - The independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapy.
Wang L, Sheng L, Liu P. Wang L, et al. Int J Clin Exp Med. 2015 Nov 15;8(11):21215-21. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885057 Free PMC article. - A systematic review of the association between circulating concentrations of C reactive protein and cancer.
Heikkilä K, Ebrahim S, Lawlor DA. Heikkilä K, et al. J Epidemiol Community Health. 2007 Sep;61(9):824-33. doi: 10.1136/jech.2006.051292. J Epidemiol Community Health. 2007. PMID: 17699539 Free PMC article. Review. - Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.
DeMichele A, Gray R, Horn M, Chen J, Aplenc R, Vaughan WP, Tallman MS. DeMichele A, et al. Cancer Res. 2009 May 15;69(10):4184-91. doi: 10.1158/0008-5472.CAN-08-2989. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous